$AGN Company News Paulson takes stake in Abbvi
Post# of 94265
Posted On: 11/15/2014 10:02:29 AM
$AGN Company News
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
If you're looking big pharma, look no further than Actavis 1:05 p.m. Nov. 13, 2014 - The Trading Deck
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Energy stocks sap S&P 500 4:22 p.m. Oct. 27, 2014 - Barbara Kollmeyer
Allergan shares advance 1.1% 9:31 a.m. Oct. 27, 2014 - Sue Chang
Allergan board skeptical of Valeant's offer to improve bid 9:28 a.m. Oct. 27, 2014 - Ciara Linnane
Allergan board says would consider an increased Valeant offer 9:13 a.m. Oct. 27, 2014 - Ciara Linnane
‘Monsters under the bed’ threaten market’s seasonal boost 9:09 a.m. Oct. 27, 2014 - Shawn Langlois
4 warnings for companies after Amazon’s spectacular loss 8:30 a.m. Oct. 27, 2014 - Marek Fuchs
Allergan raises outlook, Valeant may improve bid 7:48 a.m. Oct. 27, 2014 - MarketWatch.com
Allergan shares up 3.1% in premarket trade 7:14 a.m. Oct. 27, 2014 - Ciara Linnane
Valeant willing to improve Allergan offer to value of at least $200 a share 7:11 a.m. Oct. 27, 2014 - Ciara Linnane
Valeant urges Allergan board to take control of process 6:57 a.m. Oct. 27, 2014 - Ciara Linnane
Valeant says willing to improve Allergan offer to value of at least $200 a share 6:57 a.m. Oct. 27, 2014 - Ciara Linnane
Halliburton Turns Hostile on Baker Hughes 9:53 p.m. Nov. 14, 2014 - The Wall Street Journal Interactive Edition
Valeant Should Drop Allergan Bid And Go For Zoetis 8:30 a.m. Nov. 14, 2014 - Seeking Alpha
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
Will Actavis Snatch Allergan, Valeant Settle for Zoetis? - Analyst Blog 5:28 p.m. Nov. 13, 2014 - Zacks.com
Ackman's Pershing Group Buys Stake in Zoetis 10:23 a.m. Nov. 13, 2014 - GuruFocus.com
Valeant, Allergan Fight for Doctors 7:45 p.m. Nov. 12, 2014 - The Wall Street Journal Interactive Edition
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog 5:00 p.m. Nov. 12, 2014 - Zacks.com
Analyst: Bill Ackman's Zoetis Move Casts Doubt On Allergan Bid 3:04 p.m. Nov. 12, 2014 - benzinga.com
3 Stocks Moving The Drugs Industry Upward 12:25 p.m. Nov. 12, 2014 - TheStreet.com
Actavis closing in on Allergan 12:22 p.m. Nov. 12, 2014 - Seeking Alpha
Actavis, Allergan Reported Near Deal As Valeant Lurks 11:43 a.m. Nov. 12, 2014 - Investors Business Daily
Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog 11:00 a.m. Nov. 12, 2014 - Zacks.com
Allergan Spikes Higher On Acquisition Report 9:45 a.m. Nov. 12, 2014 - benzinga.com
Allergan tweaks bylaws pertaining to special meeting requests 8:07 a.m. Nov. 12, 2014 - Seeking Alpha
Tracking The Parnassus Core Equity Fund 7:45 a.m. Nov. 12, 2014 - Seeking Alpha
Mergers and Acquisitions: Zoetis a Buy on Ackman Stake 3:12 a.m. Nov. 12, 2014 - InvestorPlace.com
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog 6:41 p.m. Nov. 11, 2014 - Zacks.com
Dendreon Shares Plummet After It Files for Bankruptcy - Analyst Blog 4:45 p.m. Nov. 11, 2014 - Zacks.com
Ackman Takes Stake in Animal-Health Company 4:25 p.m. Nov. 11, 2014 - The Wall Street Journal Interactive Edition
Zoetis could be fallback option for Valeant 4:16 p.m. Nov. 11, 2014 - Seeking Alpha
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
Allergan Canada Launches a 3D JUVEDERM(R) Visualization iPad App Powered by ModiFace 9:02 a.m. Oct. 29, 2014 - Marketwired
Allergan Comments on Valeant Letter 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Allergan Announces Quarterly Conference Call 1:00 p.m. Oct. 24, 2014 - BusinessWire - BZX
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global Botulinum Toxin Market 4:17 p.m. Oct. 23, 2014 - PR Newswire - PRF
New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent 9:20 a.m. Oct. 23, 2014 - PR Newswire - PRF
Principled Equity Market Fund (PEQKL) Performance Close to Benchmark through Third Quarter of the Year 2:05 p.m. Oct. 22, 2014 - BusinessWire - BZX
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt 8:40 a.m. Oct. 20, 2014 - PR Newswire - PRF
Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in the World 8:02 a.m. Oct. 15, 2014 - BusinessWire - BZX
Allergan Provides Update on Earnings Per Share and Sales Expectations 6:45 a.m. Oct. 9, 2014 - BusinessWire - BZX
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
If you're looking big pharma, look no further than Actavis 1:05 p.m. Nov. 13, 2014 - The Trading Deck
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Energy stocks sap S&P 500 4:22 p.m. Oct. 27, 2014 - Barbara Kollmeyer
Allergan shares advance 1.1% 9:31 a.m. Oct. 27, 2014 - Sue Chang
Allergan board skeptical of Valeant's offer to improve bid 9:28 a.m. Oct. 27, 2014 - Ciara Linnane
Allergan board says would consider an increased Valeant offer 9:13 a.m. Oct. 27, 2014 - Ciara Linnane
‘Monsters under the bed’ threaten market’s seasonal boost 9:09 a.m. Oct. 27, 2014 - Shawn Langlois
4 warnings for companies after Amazon’s spectacular loss 8:30 a.m. Oct. 27, 2014 - Marek Fuchs
Allergan raises outlook, Valeant may improve bid 7:48 a.m. Oct. 27, 2014 - MarketWatch.com
Allergan shares up 3.1% in premarket trade 7:14 a.m. Oct. 27, 2014 - Ciara Linnane
Valeant willing to improve Allergan offer to value of at least $200 a share 7:11 a.m. Oct. 27, 2014 - Ciara Linnane
Valeant urges Allergan board to take control of process 6:57 a.m. Oct. 27, 2014 - Ciara Linnane
Valeant says willing to improve Allergan offer to value of at least $200 a share 6:57 a.m. Oct. 27, 2014 - Ciara Linnane
Halliburton Turns Hostile on Baker Hughes 9:53 p.m. Nov. 14, 2014 - The Wall Street Journal Interactive Edition
Valeant Should Drop Allergan Bid And Go For Zoetis 8:30 a.m. Nov. 14, 2014 - Seeking Alpha
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
Will Actavis Snatch Allergan, Valeant Settle for Zoetis? - Analyst Blog 5:28 p.m. Nov. 13, 2014 - Zacks.com
Ackman's Pershing Group Buys Stake in Zoetis 10:23 a.m. Nov. 13, 2014 - GuruFocus.com
Valeant, Allergan Fight for Doctors 7:45 p.m. Nov. 12, 2014 - The Wall Street Journal Interactive Edition
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog 5:00 p.m. Nov. 12, 2014 - Zacks.com
Analyst: Bill Ackman's Zoetis Move Casts Doubt On Allergan Bid 3:04 p.m. Nov. 12, 2014 - benzinga.com
3 Stocks Moving The Drugs Industry Upward 12:25 p.m. Nov. 12, 2014 - TheStreet.com
Actavis closing in on Allergan 12:22 p.m. Nov. 12, 2014 - Seeking Alpha
Actavis, Allergan Reported Near Deal As Valeant Lurks 11:43 a.m. Nov. 12, 2014 - Investors Business Daily
Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog 11:00 a.m. Nov. 12, 2014 - Zacks.com
Allergan Spikes Higher On Acquisition Report 9:45 a.m. Nov. 12, 2014 - benzinga.com
Allergan tweaks bylaws pertaining to special meeting requests 8:07 a.m. Nov. 12, 2014 - Seeking Alpha
Tracking The Parnassus Core Equity Fund 7:45 a.m. Nov. 12, 2014 - Seeking Alpha
Mergers and Acquisitions: Zoetis a Buy on Ackman Stake 3:12 a.m. Nov. 12, 2014 - InvestorPlace.com
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog 6:41 p.m. Nov. 11, 2014 - Zacks.com
Dendreon Shares Plummet After It Files for Bankruptcy - Analyst Blog 4:45 p.m. Nov. 11, 2014 - Zacks.com
Ackman Takes Stake in Animal-Health Company 4:25 p.m. Nov. 11, 2014 - The Wall Street Journal Interactive Edition
Zoetis could be fallback option for Valeant 4:16 p.m. Nov. 11, 2014 - Seeking Alpha
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
Allergan Canada Launches a 3D JUVEDERM(R) Visualization iPad App Powered by ModiFace 9:02 a.m. Oct. 29, 2014 - Marketwired
Allergan Comments on Valeant Letter 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Allergan Announces Quarterly Conference Call 1:00 p.m. Oct. 24, 2014 - BusinessWire - BZX
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global Botulinum Toxin Market 4:17 p.m. Oct. 23, 2014 - PR Newswire - PRF
New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent 9:20 a.m. Oct. 23, 2014 - PR Newswire - PRF
Principled Equity Market Fund (PEQKL) Performance Close to Benchmark through Third Quarter of the Year 2:05 p.m. Oct. 22, 2014 - BusinessWire - BZX
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt 8:40 a.m. Oct. 20, 2014 - PR Newswire - PRF
Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in the World 8:02 a.m. Oct. 15, 2014 - BusinessWire - BZX
Allergan Provides Update on Earnings Per Share and Sales Expectations 6:45 a.m. Oct. 9, 2014 - BusinessWire - BZX
(0)
(0)